AARDVARK THERAPEUTICS INC (AARD) Stock Earnings & Estimates
USA - NASDAQ:AARD - US0029421007 - Common Stock
11.455 USD
-0.51 (-4.22%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 1,300.00% | ||||
| EBITDA YoY % growth | -10.253M | -7.318M 28.63% | -22.769M -211.14% | N/A -154.03% | N/A -28.12% | N/A -36.10% | |
| EBIT YoY % growth | -10.363M | -7.415M 28.45% | -22.785M -207.28% | N/A -168.92% | N/A -28.57% | N/A -50.47% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -8.48% | N/A -7.91% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.82 | -0.91 | -0.85 -19.24% | -0.95 -43.73% | -0.88 -6.83% | -0.98 -7.87% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.074M -274.66% | -21.803M -130.71% | -19.38M -85.10% | -21.42M -35.16% | -19.89M -4.28% | -21.93M -0.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.66 | -0.61 | -0.05 | -7.84% |
| Q1 2025 Q2Q % growth | -0.71 | -0.69 | -0.02 | -3.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.92% | -12.98% | 2.13% | -1.63% |
| Revenue | N/A | N/A | N/A | N/A |